Association of Metformin Use With End‐Stage Renal Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study Under the Pay‐for‐Performance Program
- 4 June 2019
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 59 (11) , 1443-1452
Abstract
Animal studies have demonstrated that metformin exerts a renoprotective effect. Human studies of patients with diabetes mellitus (DM) regarding the association of metformin use with end‐stage renal disease (ESRD) are lacking. Patients with type 2 DM and without a history of kidney disease who were enrolled under the pay‐for‐performance program of the National Health Insurance in Taiwan were identified. Those who received ≥90 cumulative defined daily doses of metformin within 1 year were selected (metformin users) and compared with a 1:1 propensity score–matched metformin nonuser cohort. Primary and secondary outcomes were development of ESRD and chronic kidney disease (CKD), respectively. Independent predictors were investigated using Cox regression analysis. A total of 24 158 pairs of metformin users and nonusers were enrolled, with an incidence of ESRD of 1908 and 1723 and CKD of 1095 and 1056 cases per 100 000 person‐years, respectively. Metformin use was independently associated with increased risks of ESRD (adjusted hazard ratio, 1.22; 95% confidence interval, 1.12‐1.32) and CKD (adjusted hazard ratio, 1.25; 95% confidence interval, 1.12‐1.40) in a dose‐response relationship. Patients with hypertension plus nonuse of angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers potentiated kidney damage by metformin. In patients with DM, use of metformin may increase the risk of ESRD and CKD. Health care professionals should be alert and closely monitor renal function when prescribing metformin.Keywords
Funding Information
- Ministry of Health and Welfare (MOHW105‐CDC‐C‐114‐00103, MOHW106‐CDC‐C‐11400104)
- Ministry of Science and Technology, Taiwan (MOST104‐2321‐B‐002‐058)
This publication has 33 references indexed in Scilit:
- Metformin overdose, but not lactic acidosis per se, inhibits oxygen consumption in pigsCritical Care, 2012
- Early Treatment With Olmesartan Prevents Juxtamedullary Glomerular Podocyte Injury and the Onset of Microalbuminuria in Type 2 Diabetic RatsAmerican Journal of Hypertension, 2012
- Use of Metformin in the Setting of Mild-to-Moderate Renal InsufficiencyDiabetes Care, 2011
- Insulin and metformin may prevent renal injury in young type 2 diabetic Goto–Kakizaki ratsEuropean Journal of Pharmacology, 2011
- Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockadeJournal Of Hypertension, 2010
- Impact of Metformin-Induced Gastrointestinal Symptoms on Quality of Life and Adherence in Patients with Type 2 DiabetesPostgraduate Medicine, 2010
- Irbesartan treatment of patients with type 2 diabetes, hypertension and renal disease: a UK health economics analysisInternational Journal Of Clinical Practice, 2007
- Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialThe Lancet, 2007
- Obesity and Risk for Chronic Renal FailureJournal of the American Society of Nephrology, 2006
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001